Patent details
EP1286665 Title: TREATMENT REGIMEN OF INTRAVENOUS ZOLEDRONATE FOR THE TREATMENT OF BONE METABOLISM DISEASES
Basic Information
- Publication number:
- EP1286665
- PCT Application Number:
- PCT/US/2001/014886
- Type:
- European Patent Granted for LU
- Legal Status:
- Revoked
- Application number:
- EP019351675
- PCT Publication Number:
- WO/2001/089494
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT REGIMEN OF INTRAVENOUS ZOLEDRONATE FOR THE TREATMENT OF BONE METABOLISM DISEASES
- French Title of Invention:
- SCHEMA DE TRAITEMENT DU ZOLEDRONATE POUR LES MALADIES DE METABOLISME OSSEUX
- German Title of Invention:
- BEHANDLUNGSSCHEMA VON ZOLEDRONAT ZUR BEHANDLUNG VON ERKRANKUNGEN DES KNOCHENMETABOLISMUS
- SPC Number:
Dates
- Filing date:
- 09/05/2001
- Grant date:
- 17/04/2013
- EP Publication Date:
- 17/04/2013
- PCT Publication Date:
- 29/11/2001
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 05/03/2003
- EP B1 Publication Date:
- 17/04/2013
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 09/05/2021
- Renunciation date:
- Revocation date:
- 09/05/2013
- Annulment date:
Owner
- From:
- 09/05/2001
- Name:
- Novartis AG
- Address:
- Lichtstrasse 35, 4056 Basel, Switzerland (CH)
- Name:
- Novartis Pharma GmbH
- Address:
- Brunner Strasse 59, 1230 Wien, Austria (AT)
Inventor
1
- Name:
- SEAMAN John, J.
- Address:
- United States (US)
2
- Name:
- GALLI Bruno
- Address:
- Switzerland (CH)
3
- Name:
- SCHRAN Horst
- Address:
- United States (US)
Priority
- Priority Number:
- 0012209
- Priority Date:
- 19/05/2000
- Priority Country:
- United Kingdom (GB)
Classification
- Main IPC Class:
- A61K 31/662;
| Filing date | Document type | Number of pages |
|---|